I wouldn't take this one too lightly given the set of recent news, check it.
June 7, 2012 4:30a Amarantus BioSciences and Banyan Biomarkers Announce Positive Data from Traumatic Brain Injury Collaboration (PR NewsWire) June 6, 2012 5:32a Amarantus BioSciences to Present at the National Investment Banking Association's (NIBA)122nd Conference in New York City (PR NewsWire) May 31, 2012 5:00a RBCC Anticipates Favorable Test Results of New Brain Injury Treatment (Business Wire) May 30, 2012 6:00a Amarantus BioSciences President & CEO Gerald Commissiong, talks live with 'The Stock Radio' from Wall Street 1-2-1 event in Orlando, Florida (PR NewsWire) May 16, 2012 5:00a RBCC, Amarantus Move Forward with Joint Venture Discussions (Business Wire) May 9, 2012 6:00a Amarantus BioSciences to Present at the Wall Street 1-2-1 Conference (PR NewsWire) May 7, 2012 5:59a Amarantus BioSciences Issues First Annual CEO Letter to Shareholders (PR NewsWire) May 4, 2012 5:00a RBCC Target's Brain Injury Treatment Awareness Campaign Reaches Milestone (Business Wire) May 3, 2012 5:00a RBCC: Global Scientific Community Embraces New Parkinson's Therapy (Business Wire) May 1, 2012 7:45a Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012 (PR NewsWire) April 30, 2012 5:00a Rainbow Biosciences, LLC Enters into Letter of Intent with Amarantus BioSciences to Advance Parkinson's Disease Program (Business Wire) April 26, 2012 7:00a Brewer Sports International and Amarantus BioSciences launch #C4CT to raise awareness for concussion treatments in development (PR NewsWire) March 19, 2012 9:50a Amarantus BioSciences Reports Addition of New Scientific Articles to MANF Publications List (PR NewsWire)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.